Avivia is an independent specialized pharmaceutical development company engaged in drug repositioning, repurposing and reformulation. We operate a hybrid business model combining CRO service activities with internal product development programs, whereby in both cases, we approach ‘development’ as not just offering a technical solution but always part of a broader product-oriented strategy. Our CRO services comprises complex drug product development and analytical development with unique dissolution and excipient characterization platforms. 

Related Categories

Sales Markets

Middle East Region (e.g. UAE); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries)